Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 4

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 4
---
 reference is made to the actual
documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the
documents referred to herein have been or will be filed or have been or will be incorporated by reference as exhibits to the registration
statement of which this prospectus forms a part, and you may obtain copies of those documents as described in this prospectus supplement
under the heading “Where You Can Find More Information.”

You should rely only on the information that we have included or incorporated by reference in this prospectus and any related free writing prospectus that we may authorize to be provided to you. We have not authorized any dealer, salesman or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus or any related free writing prospectus that we may authorize to be provided to you. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or any related free writing prospectus. This prospectus and any related free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus or any related free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

For investors outside the United States (“U.S.”):
We have not done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where
action for those purposes is required, other than in the U.S. Persons outside the U.S. who come into possession of this prospectus must
inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus
outside of the U.S.

References to the “Company,” “BioVie,”
“we,” “us,” “our” and similar terms in this prospectus are to BioVie Inc. and its consolidated subsidiaries,
unless the context otherwise requires. This document includes trade names and trademarks of other companies. All such trade names and
trademarks appearing in this document are the property of their respective holders.

| 1 |

<div align='center'>Prospectus Summary</div>

This summary highlights certain information about us and certain information contained elsewhere in this prospectus and in the documents incorporated by reference herein. This summary is not complete and